Egypt to produce 60mln doses of Sinovac vaccine from next month

PHOTO

CAIRO: Egypt is set to begin the production of 60 million doses of the Chinese Sinovac coronavirus disease (COVID-19) vaccine next month.

The announcement was made by Mohammed Abdel Fattah, head of the central administration for preventive affairs at Egypt’s Ministry of Health. The health official stressed that the goal was to ensure vaccination for as large a number of citizens as possible.

In televised statements, Fattah said that the elderly and those working in the medical sector would be among the prioritized categories of people to receive the vaccine, followed by those working in the tourism and banking sector.

He indicated that large doses of vaccines would become available in the coming days and confirmed that Egypt was able to procure a variety of vaccines, including the Chinese Sinovac and AstraZeneca vaccines. It has also contracted to receive the Russian Sputnik V vaccine.

Fattah said although there has been a significant increase in COVID-19 cases recently, medicines and oxygen tanks were available, and hospitals were ready to receive critical patients.

He said that a number of vaccination centers in the country had been opened that would allow a large number of citizens to be inoculated at the same time.

The vaccine center in the area of the Cairo International Fair accepts citizens from the governorates of Cairo, Giza and Al-Qalioubiya. Its daily capacity reaches 10,000 people, and it includes 96 clinics and a medical team.

Fattah called on citizens to sign up for the vaccine, noting that the demand among Egyptians to become vaccinated has increased, especially after the outbreak of the Indian variant.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.